Brief: French biopharmaceutical company NFL Biosciences SA raises 5 mln euros via Euronext IPO

Nfl Biosciences SAS

05/07/2021 07:09

July 5 (Reuters) - NFL Biosciences SA  ALNFL.PA :
    * REG-NFL BIOSCIENCES RAISES €5.0M FOLLOWING ITS SUCCESSFUL
INITIAL PUBLIC OFFERING ON EURONEXT GROWTH PARIS®
    * REG-NFL BIOSCIENCES RAISES €5.0M FOLLOWING ITS SUCCESSFUL
INITIAL PUBLIC OFFERING ON EURONEXT GROWTH PARIS®
    * PRICE SET AT EUR 3.80 PER SHARE
    * CAPITAL INCREASE FOR A GROSS TOTAL OF EUR 5M
    * PRICE SET AT EUR 3.80 PER SHARE
    * NFL Biosciences SA is a biopharmaceutical company
developing
botanical drugs for the treatment of addictions

Source text for Eikon:  ID:nGNE996s5Q 
Further company coverage:  ALNFL.PA 

 (Reporting by Sudip Kar-Gupta)
 ((sudip.kargupta@thomsonreuters.com;))